Literature DB >> 7006142

Aspirin-dipyridamole prophylaxis of sickle cell disease pain crises.

H Chaplin, N Alkjaersig, A P Fletcher, J M Michael, J H Joist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7006142

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  15 in total

Review 1.  Redox-dependent impairment of vascular function in sickle cell disease.

Authors:  Mutay Aslan; Bruce A Freeman
Journal:  Free Radic Biol Med       Date:  2007-08-31       Impact factor: 7.376

2.  A study of beta-thromboglobulin and platelet factor-4 plasma levels in steady state sickle cell patients.

Authors:  S Adamides; K Konstantopoulos; M Toumbis; D Douratsos; A Travlou; A Kasfiki
Journal:  Blut       Date:  1990-10

Review 3.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

4.  Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice.

Authors:  Paritha I Arumugam; Eric S Mullins; Shiva Kumar Shanmukhappa; Brett P Monia; Anastacia Loberg; Maureen A Shaw; Tilat Rizvi; Janaka Wansapura; Jay L Degen; Punam Malik
Journal:  Blood       Date:  2015-08-18       Impact factor: 22.113

Review 5.  Interplay between coagulation and vascular inflammation in sickle cell disease.

Authors:  Erica Sparkenbaugh; Rafal Pawlinski
Journal:  Br J Haematol       Date:  2013-04-18       Impact factor: 6.998

Review 6.  Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.

Authors:  Denis Noubouossie; Nigel S Key; Kenneth I Ataga
Journal:  Blood Rev       Date:  2015-12-24       Impact factor: 8.250

7.  Tissue type plasminogen activator antigen and activity in sickle cell disease.

Authors:  R B Francis
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

8.  Morphological and functional platelet abnormalities in Berkeley sickle cell mice.

Authors:  Arun S Shet; Thomas J Hoffmann; Marketa Jirouskova; Christin A Janczak; Jacqueline R M Stevens; Adewole Adamson; Narla Mohandas; Elizabeth A Manci; Therese Cynober; Barry S Coller
Journal:  Blood Cells Mol Dis       Date:  2008-04-18       Impact factor: 3.039

9.  A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease.

Authors:  Payal C Desai; Julia E Brittain; Susan K Jones; Adam McDonald; Douglas R Wilson; Rosalie Dominik; Nigel S Key; Leslie V Parise; Kenneth I Ataga
Journal:  Thromb Res       Date:  2013-08-08       Impact factor: 3.944

10.  Advances in new drug therapies for the management of sickle cell disease.

Authors:  Kenneth I Ataga; Payal C Desai
Journal:  Expert Opin Orphan Drugs       Date:  2018-05-14       Impact factor: 0.694
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.